Longboard Pharmaceuticals

Longboard Pharmaceuticals

A clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Learn more

Launch date
Employees
Market cap
€1.2b
Enterprise valuation
€903m (Public information from Sep 2024)
San Diego California (HQ)
Authorizing premium user...